Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 08-2025 | 05-2025 | 02-2025 | 11-2024 | 08-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 943 | 378 | 639 | 166 | 3 |
| Receivables | 117 | 86 | 70 | 52 | 37 |
| Inventories | 153 | 85 | 67 | 67 | 10 |
| TOTAL | $1,261 | $648 | $876 | $359 | $130 |
| Non-Current Assets | |||||
| PPE Net | 2,403 | 2,288 | 2,268 | 2,226 | 2,190 |
| Other Non-Current Assets | 14 | 14 | 14 | 14 | 14 |
| TOTAL | $2,417 | $2,302 | $2,282 | $2,240 | $2,204 |
| Total Assets | $3,678 | $2,951 | $3,158 | $2,598 | $2,334 |
| Liabilities | |||||
| Current Liabilities | |||||
| Other current liabilities | N/A | N/A | N/A | 167 | N/A |
| TOTAL | $2,181 | $1,983 | $1,917 | $2,094 | $1,336 |
| Non-Current Liabilities | |||||
| Long Term Debt | 40 | 40 | 40 | 40 | 40 |
| Deferred Revenues | 227 | 282 | 350 | N/A | N/A |
| Other Non-Current Liabilities | 14 | 14 | 14 | 14 | 14 |
| TOTAL | $54 | $54 | $54 | $54 | $54 |
| Total Liabilities | $2,235 | $2,037 | $1,971 | $2,148 | $1,390 |
| Shareholders' Equity | |||||
| Common Shares | 12,562 | 10,944 | 10,659 | 9,139 | 9,200 |
| Retained earnings | -13,502 | -12,197 | -11,653 | -10,835 | -10,377 |
| Other shareholders' equity | 12 | 17 | 30 | 21 | 18 |
| TOTAL | $1,443 | $914 | $1,186 | $450 | $945 |
| Total Liabilities And Equity | $3,678 | $2,951 | $3,158 | $2,598 | $2,334 |